Innovative collaboration aims to boost the nation’s role as a leading cell and gene therapy manufacturer and clinical services through enabling translational research and development SINGAPORE, Singapore — Agilent Technologies Inc. (NYSE: A) recently signed a Memorandum of Understanding (MOU) with the Advanced Cell Therapy and Research Institute, Singapore (ACTRIS), to develop cell and gene therapy […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a drug discovery agreement with Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; “Ono”) to discover and develop novel antibodies for the treatment of autoimmune diseases. […]
Agreements Will Help Drive Greater Accuracy of Epigenetic Information for the Early Detection of Cancer BOULDER,CO – Watchmaker Genomics, a supplier of innovative products for molecular analysis, today announced a multi-year, co-exclusive agreement with Exact Sciences Corporation, a leading provider of cancer screening and diagnostic tests, to develop and commercialize the breakthrough DNA methylation analysis technology, TET-assisted pyridine […]
Strategic distribution agreement with Research Instruments expands access to BioSkryb’s best-in-class single-cell multiomics portfolio throughout Southeast Asia DURHAM, N.C. – BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, today announced a partnership with Research Instruments Pte Ltd, a premier distributor for genomic […]
San Jose, CA (USA) & Hamburg (Germany) — Takara Bio Inc. (Takara Bio) and Eppendorf SE, two renowned leaders in the life science industry, are pleased to announce their collaboration through a strategic co-marketing agreement. This partnership aims at jointly developing cutting-edge solutions to automate Takara Bio’s chemistries on Eppendorf epMotion® automation platforms. “The integration […]
Research labs will see time and cost savings while reducing risk and ensuring compliance with reagent safety Research Triangle, NC: JAGGAER, the global leader in Autonomous Commerce, is collaborating with Chemwatch, the international leader in enhanced chemicals management, to enable researchers to comply with safety standards across the full lifecycle for chemical reagents while saving […]
Results generated to date serve as basis for new IP filings and conference presentations, and have led to an expansion of the collaboration beyond CAR T cells SAN FRANCISCO — Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced it has achieved key milestones in its R&D collaboration with Labcorp, […]
The recently launched HaLCon Analyzer from RedShiftBio and the Flownamics Director are perfectly suited to jointly deliver HPLC-quality protein titer for bioprocessing with even greater efficiency and throughput. BOXBOROUGH, Mass. — RedShift BioAnalytics (RedShiftBio®) today announced that it has signed a global distribution agreement with Flownamics for the Director™ Sample Distribution System. The Director™ from Flownamics […]
Synthego to develop multiplexed and complex genetic engineering strategies, increasing the safety and speed at which bit.bio can engineer human cells for cell therapies. bit.bio aims to leverage technology to increase efficiency of human cell engineering and accelerate the development of highly scalable cell therapies that are capable of treating millions of patients. Redwood City, […]
Rentschler Biopharma, Cell and Gene Therapy Catapult and Refeyn announce collaboration The collaborators will use automated and digital technologies to improve the process of manufacturing adeno-associated viruses (AAV) Stevenage and London, UK, and Laupheim, Germany– Rentschler Biopharma, a leading global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), announces a […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
